Jobs
-
The US Supreme Court ruled unanimously that Matrixx Initiatives was wrong when it claimed that it did not have to disclose reports of adverse effects caused by its Zicam nasal spray because the number of… Read more . . .
-
Send workshop and paper proposals by Friday, 29th April 2011. The main theme for the 2012 conference will be sustainability Possible paper and workshop themes may be: new areas of application, materials, surface treatment, shaping,… Read more . . .
-
According to Virginia biotech company Insmed, the US FDA has cleared the company’s Investigational New Drug (IND) application for a Phase 3 trial of its Arikace liposomal amikacin for inhalation in nontuberculous mycobacteria lung infections.… Read more . . .
-
According to reports, Novartis will close its manufacturing facility at Horsham, UK, cutting 550 jobs, but will maintain its respiratory research program at the site. The company employs approximately 330 researchers in the respiratory program.… Read more . . .
-
The Allergy and Asthma Network Mothers of Asthmatics (AANMA) has published results of a new survey of US asthma patients. Of the patients surveyed, 100% reported use of a short-acting bronchodilator, and 95% reported that… Read more . . .
-
An article published in the March 17, 2011 issue of the New England Journal of Medicine details a study by researchers from the Boston University School of Medicine showing that omalizumab reduces the need for… Read more . . .
-
Almirall has launched Sativex oro-mucosal spray for the treatment of spasticity in multiple sclerosis patients in Spain. Sativex is an endocannabinoid modulator that contains THC and cannabidiol developed and manufactured by GW Pharmaceuticals. According to… Read more . . .
-
According to New York specialty pharmaceutical company Hi-Tech Pharmacal, sales of its generic fluticasone propionate nasal spray increased 562% during the quarter ending January 31, 2011. Total sales for the product reached $17.9 million for… Read more . . .
-
Submit speaker abstracts by August 1, 2011; submit nominations for the Charles G Thiel Award by November 30, 2011; and submit poster abstracts by January 13, 2012. For more information, see RDD Online. Read more . . .
-
The Pulmonary-Allergy Drugs Advisory Committee (PADAC) of the US FDA has voted to recommend approval of the 75 mcg dose of Novartis’s QAB149 indacaterol dry powder formulation for the treatment of COPD but has voted… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland